Cargando…
Use of Photodynamic Therapy for Treatment of Actinic Keratoses in Organ Transplant Recipients
Solid organ transplant recipients are predisposed to actinic keratoses (AK) and nonmelanoma skin cancers, owing to the lifelong immunosuppression required. Today, increasing numbers of organ transplants are being performed and organ transplant recipients (OTRs) are surviving much longer. Photodynami...
Autores principales: | Wlodek, Christina, Ali, Faisal R., Lear, John T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591189/ https://www.ncbi.nlm.nih.gov/pubmed/23509711 http://dx.doi.org/10.1155/2013/349526 |
Ejemplares similares
-
The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses
por: Ali, Faisal R., et al.
Publicado: (2012) -
Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments)
por: Hasan, Zeeshaan‐Ul, et al.
Publicado: (2022) -
Sequential Treatment of Multiple Actinic Keratoses with Solaraze and Actikerall
por: Dirschka, Thomas, et al.
Publicado: (2014) -
Ablative Fractional Laser-assisted Low-irradiance Photodynamic Therapy for Treatment of Actinic Keratoses in Organ Transplant Recipients: A Prospective, Randomized, Intraindividual Controlled Trial
por: LONSDORF, Anke S., et al.
Publicado: (2022) -
Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients
por: Hameetman, Liesbeth, et al.
Publicado: (2013)